NCT03389308 - Long Term Open-label Study Evaluating Safety of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

April 17, 2020

Study Completion Date

April 17, 2020

Conditions

Epidermolysis BullosaEpidermolysis Bullosa Simplex

Interventions

DRUG

diacerein 1% ointment

"Topically apply study medication to lesions identified by the Investigator that require.~treatment"

Trial Locations (3)

University of North Carolina (UNC) - Chapel Hill, Chapel Hill

Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago

Children's Hospital of San Antonio, San Antonio